Mallinckrodt and Endo , drugmakers which recently emerged from bankruptcy after a wave of U.S. opioid lawsuits, announced ...
Mallinckrodt Pharmaceuticals and Endo Inc. are exploring a potential merger that could be valued at about $7 billion, people ...
(Reuters) - Mallinckrodt and Endo, drugmakers with a shared history of facing U.S. opioid litigation, have agreed to merge in ...
EAST WHITELAND — Endo, a pharmaceutical company that has its global headquarters in Chester County, is being acquired by Ireland’s Mallinckrodt in a cash-and-stock deal valued at $6.7 billion.
Mallinckrodt Pharmaceuticals and Endo Inc. plan to merge and create a $6.7 billion company in a move that will cut costs and broaden access to patients and new treatments.
Ireland’s Mallinckrodt will buy U.S. drugmaker Endo in a cash-and-stock deal valued at $6.7 billion. The companies said Thursday that Endo shareholders will receive a total of $80 million in cash and ...
Mallinckrodt and Endo are exploring a potential merger that could be valued at about $7 billion, person familiar with the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results